These 7 were hand-picked from the list of 220 Zacks Rank #1 Strong Buys with earnings estimate revisions that are sweeping upward. Their stock prices are expected to rise sooner than the others. Today, this Special Report will be available to ... Zacks.com, 1 month ago
1 images for "amgen rank"
Aug. 3, 2015 11:40 AM ET | About: Amgen Inc. (AMGN), Includes: AZN, BIIB, GSK, IBB, NVS, PFE, REGN, RHHBY, SNY, VRTX by: DoctoRx Summary Amgen, a famous mega-cap biotech, has reported a beat-and-raise quarter. The stock has surged to an ...Seeking Alpha, 1 month ago Amgen (AMGN) Trading Near $166.36 Resistance Level TradingCharts.com, 1 month ago Amgen (AMGN) Showing Bullish Technicals With Support At $159.56 Individual.com, 1 month ago
For a hedged play on Amgen Inc ( AMGN ) MarketIntelligenceCenter.comaEUR(TM)s algorithms selected the Sep. '15 $170.00 covered call for a net debit in the $160.76 area. That is also the break-even stock price for the covered call. This trade will ...TradingCharts.com, 1 month ago Potential Amgen (AMGN) Trade Has 3.37% Downside Protection Individual.com, 1 month ago Potential Amgen (AMGN) Trade Has 2.05% Downside Protection Individual.com, 2 months ago
U BS downgraded Regeneron (NASDAQ: REGN ) and Amgen (NASDAQ: AMGN ) and adjusted the price targets on several other biotech stocks Thursday on the grounds that the sector may be in for a slow patch. "Although we still think that biotech will ...Investor's Business Daily, 1 month ago
Follow Comments Following Comments Unfollow Comments Amgen Inc (NASD: AMGN) has been named as a Top 25 Dividend Giant by ETF Channel, with a staggering $5.53B worth of stock held by ETFs, and above-average DividendRank statistics including a ...Forbes.com, 1 month ago
Biotech major, Amgen ( AMGN - Analyst Report ), reported second quarter 2015 earnings of $2.57 per share, soaring above the Zacks Consensus Estimate of $2.43 and the year-ago earnings of $2.37. Earnings were driven by higher revenues and lower ...Zacks.com, 1 month ago Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? Zacks.com, 1 month ago
FDA approves carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma
, the U. S. Food and Drug Administration approved carfilzomib (Kyprolis, Onyx Pharmaceuticals, Inc., an Amgen subsidiary) in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have ...Ecancer Medicalscience, 1 month ago Amgen Reports Positive Data on Leukemia Drug Blincyto Zacks.com, 1 month ago
More from: , Nasdaq...and 1 other sources
The first PCSK9 inhibitor has finally gained approval in the EU with the European Commission giving the nod to Amgen Inc. 's ( AMGN - Analyst Report ) Repatha (evolocumab). Although the EU approval was largely expected considering the Committee ...Zacks.com, 1 month ago
More from: , Individual.com...and 2 other sources
It is estimated that over 15,000 students in Ireland will benefit from Amgen foundation science education investments during the coming academic year. The company who opened a new $300 million facility in Dublin yesterday claimed that more ...Ireland Business World, 1 week ago
Shares of Emergent Biosolutions Rank the Lowest in Terms of Projected Earnings Growth in the Biotechnology Industry (EBS, UTHR, ALXN, AMGN, REGN)
Written on Thu, 07/16/2015 - 4:41am By Amy Schwartz Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) ...Comtex SmarTrend, 1 month ago Lowest Future Earnings Growth in the Biotechnology Industry Detected in Shares of Gilead Sciences (GILD, AMGN, BIIB, MYGN, REGN) Comtex SmarTrend, 1 month ago Genomic Health has the Lowest Sales Growth in the Biotechnology Industry (GHDX, ALXN, PDLI, AMGN, UTHR) Comtex SmarTrend, 1 month ago Top 5 Companies in the Biotechnology Industry With the Highest PEG Ratio (CPHD, REGN, AMGN, ACOR, LGND) Comtex SmarTrend, 1 month ago
on your WebpageAdd Widget >Get your members hooked!